Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective Randomised Nordic Frostbite Treatment Study comparing tPA and iloprost therapy
2024-520291-10-01Phase 4Authorised
- Sponsor
- Helsinki University Hospital
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in frostbite comparing Alteplase (tPA) therapy with Iloprost therapy (2 arms). Planned start Jan 2025; status: authorised.
02
Drugs
tissue-plasminogen activatoriloprost
03
Conditions
frostbite
Beyond the preview
Go deeper on 2024-520291-10-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-520291-10-01.